Letter to FDA re Draft Guidance on Considerations for Use of AI
Citations
American Society of Hematology. (2025).
Letter to FDA re Draft Guidance on Considerations for Use of AI.
Retrieved from https://www.hematology.org/advocacy/testimony-and-correspondence/letter-to-fda-re-draft-guidance-on-considerations-for-use-of-ai.
American Society of Hematology.
"Letter to FDA re Draft Guidance on Considerations for Use of AI." Hematology.org.
https://www.hematology.org/advocacy/testimony-and-correspondence/letter-to-fda-re-draft-guidance-on-considerations-for-use-of-ai
(label-accessed April 28, 2025).
"American Society of Hematology."
Letter to FDA re Draft Guidance on Considerations for Use of AI, 28 Apr. 2025 ,
https://www.hematology.org/advocacy/testimony-and-correspondence/letter-to-fda-re-draft-guidance-on-considerations-for-use-of-ai.